AnaptysBio, Inc. (ANAB)
62.43
+4.75
(+8.24%)
USD |
NASDAQ |
Apr 06, 16:00
62.37
-0.06
(-0.10%)
After-Hours: 20:00
AnaptysBio SG&A Expense (TTM) : 50.74M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ADMA Biologics, Inc. | 96.42M |
| Nektar Therapeutics | 68.67M |
| Rigel Pharmaceuticals, Inc. | 115.90M |
| Vanda Pharmaceuticals, Inc. | 237.95M |
| Adaptive Biotechnologies Corp. | 167.27M |